FindTrial
Sign In

RDW as a cost effective marker for prognosis in ICU patients

Red cell distribution width RDW as a prognostic biomarker in critically ill patients - RePCIP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/07/114046
Enrollment
121
Registered
2026-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil

Sponsors

Fortis Hospital Bannerghatta Road Bengaluru
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age more than or equal to 18 years - Patients admitted in ICU

Exclusion criteria

Exclusion criteria: - Hematological malignancies - Thalassemia - Recent whole blood / PRBC transfusion less than 7 days

Design outcomes

Primary

MeasureTime frame
To evaluate the prognostic significance of red cell distribution width in predicting mortality among critically ill patients admitted to the intensive care unitTimepoint: till ICU discharge—

Secondary

MeasureTime frame
To assess the association between RDW levels at ICU admission and severity of illness. To assess the correlation between RDW and length of ICU stay. To evaluate the association between RDW and the requirement for organ support such as mechanical ventilation and vasopressor therapy. To evaluate whether RDW can serve as a simple and cost effective prognostic biomarker in resource limited settings along with routine scoring systems SOFA and APACHE II. Timepoint: till ICU discharge and 90 days after hospital discharge—

Countries

India

Contacts

Public ContactKiran Kuraning

Fortis Hospital, Bannerghatta Road, Bengaluru

kirankuraning@gmail.com08951587113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026